RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,184,540 | +308.4% | 140,849 | +509.9% | 0.15% | +272.5% |
| Q2 2023 | $290,036 | -7.0% | 23,092 | +65.5% | 0.04% | -14.9% |
| Q3 2022 | $312,000 | -83.5% | 13,953 | -87.7% | 0.05% | -71.9% |
| Q2 2022 | $1,895,000 | +34.0% | 113,151 | +139.6% | 0.17% | +36.9% |
| Q1 2022 | $1,414,000 | -34.3% | 47,234 | -32.6% | 0.12% | -25.6% |
| Q4 2021 | $2,153,000 | -22.1% | 70,100 | -20.0% | 0.16% | -17.6% |
| Q3 2021 | $2,764,000 | – | 87,652 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |